M&M chocolate chocolate candy packages are stacked in a big costco store in San Diego, California, July 12, 2025.
Kevin Carter | Getty Images News | Getty images
Candy Maker Mars said on Wednesday that he joined Biotech Company Pairwise to speed up more resilient cocoa development using Crispr– Geno -based editing technology.
The agreement gives M&M manufacturer access to the Fulcrum platform in Pairwise, which includes a library of plant lines, and gives Mars the possibility of adapting its crops to be stronger and more lasting.
CRISPR is a gene editing tool that brings rapid and precise changes to DNA. In agriculture, it is used to improve crops by targeting different features such as drought and disease resistance.
The objective is to create cocoa plants – the source of cocoa beans, which are then roasted and transformed into cocoa – which can better resist the disease, heat and other stress -related stresses that can endanger the world supply with chocolate.
In October, Starbucks Invested in two innovation farms in Central America to protect the chain coffee supply against global warming. Farms are developing coffee and resilient test technologies in climate such as drones and mechanization.
The edition of genes allows a faster and more precise development of lines than traditional reproduction, said in pairs in a press release.
CRISPR has drawn attention in recent years for its applications in health care. At the end of 2023, the Food and Drug Administration of the United States approved the first genetic treatment of sickle cell anemia.
“At Mars, we believe that CRISPR has the potential to improve cultures in order to support and strengthen global supply chains,” said Carl Jones, director of factory sciences at Mars, in the press release.
Last month, the candy giant announced an investment of $ 2 billion in American manufacturing until 2026.